A Phase 2, Open-label Study of PRAX-944 to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Escalating Multiple Oral Doses in Adults with Generalized Epileptic Syndromes with Absence Seizures.
- O'Brien, Terence John (Primary Chief Investigator (PCI))
- Germaine, Jack (Project Manager)
Project: Research